Fig. 1 · Structure
Documents & Downloads
Suritozole
GABA Receptor inverse agonist
Suritozole is an inverse agonist targeting the GABA receptor, specifically acting on benzodiazepine binding sites within GABAA ion channel complexes. This compound has demonstrated cognitive enhancement properties and is relevant in the investigation of neurodegenerative diseases. Research applications include studying the modulation of GABAergic neurotransmission and its implications in cognitive function and pathophysiology of neurological disorders.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inverse Agonist |
| CAS Number | 110623-33-1 |
| Applications | GABA Receptor inverse agonist |
| Formula | C10H10FN3S |
| Molecular Weight | 223.27 |
| Synonyms | MDL-26479 |
| SMILES | S=C1N(N=C(N1C)C2=CC=CC(F)=C2)C |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.